Back
Outlook Therapeutics Stock Predictions
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
22
OTLK
Outlook Therapeutics
Last Price:
5.24
Seasonality Move:
-4.13%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn MoreOutlook Therapeutics Stock Forecast
- Over the next 52 weeks, Outlook Therapeutics has on average historically fallen by 16.8% based on the past 8 years of stock performance.
- Outlook Therapeutics has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Outlook Therapeutics Stock Undervalued?
The current Outlook Therapeutics [OTLK] share price is $5.23. The Score for OTLK is 22, which is 56% below its historic median score of 50, and infers higher risk than normal. - OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Outlook Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Outlook Therapeutics has on average historically fallen by 16.8% based on the past 8 years of stock performance.
Outlook Therapeutics Stock Rating
Sell
22
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics overpriced?
- Outlook Therapeutics has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Outlook Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
outlooktherapeutics.com
52-Week Data
52-Week High:
18.00
52-Week Low:
4.40
Prediction Charts
Market Cap:
123.72M
Price in USD:
5.23
Volume:
254.94K
Beta:
0.37
Technical Analysis
SMA50:
6.88
SMA100:
7.27
SMA200:
7.78
52-Wk Change:
10.48%
Stock Predictions
-
Is Outlook Therapeutics stock public?
Yes, Outlook Therapeutics is a publicly traded company. -
What is the Outlook Therapeutics stock quote today?
The Outlook Therapeutics stock price is 5.23 USD today. -
How to buy Outlook Therapeutics stock online?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-17 | 6.10 | 6.04 | 6.56 | 5.97 |
| Sep-18 | 6.13 | 5.94 | 6.59 | 5.92 |
| Sep-19 | 6.07 | 6.00 | 6.16 | 5.83 |
| Sep-20 | 6.00 | 6.00 | 6.15 | 5.87 |
| Sep-23 | 6.05 | 5.58 | 6.10 | 5.57 |
| Sep-24 | 5.60 | 5.59 | 5.67 | 5.22 |
| Sep-25 | 5.56 | 5.52 | 5.79 | 5.46 |
| Sep-26 | 5.59 | 5.68 | 5.75 | 5.50 |
| Sep-27 | 5.73 | 5.56 | 5.87 | 5.56 |
| Sep-30 | 5.59 | 5.35 | 5.73 | 5.33 |
| Oct-1 | 5.47 | 5.22 | 5.47 | 5.22 |
| Oct-2 | 5.21 | 5.26 | 5.35 | 5.15 |
| Oct-3 | 5.22 | 5.25 | 5.45 | 5.10 |
| Oct-4 | 5.27 | 5.23 | 5.42 | 5.20 |
Outlook Therapeutics Earnings
Outlook Therapeutics Earnings Report: Per Share Outlook Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Outlook Therapeutics Forecast Revenue Growth
Outlook Therapeutics Stock Analysis: Historical quarterly revenues per share for Outlook Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.